Actively Recruiting
Visa-versa! Breaking Instead of Pushing the Pedals-C
Led by University of Zurich · Updated on 2025-06-13
16
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Eccentric muscle work is defined as lengthening of a muscle while applying force. It was shown that with eccentric work, muscles are able to perform four times as much power compared to usual concentric work, which results in huge training gain with a highly decreased oxygen demand and thus lower cardiovascular load. Pulmonary hypertension (PH) is a chronic condition associated with significant reduced exercise capacity and increased morbidity and mortality, resulting in reduced quality of life. Physical training has been shown to be beneficial in PH, even in severely limited patients. However, due to cardiopulmonary constraints in PH, training intensities may be very low, so that many patients are physically almost unable to perform exercise on a high enough level to maintain muscle mass. A low body muscle not only feeds the vicious cycle of decreasing exercise capacity, but also has many deleterious metabolic and immunological consequences which further increase disability and decrease quality of life in PH. Thus, eccentric training, which allows to gain muscle mass with a low stress to the cardiopulmonary unit may to be highly beneficial for patients with PH and allied cardiopulmonary disease, such as chronic obstructive pulmonary disease (COPD) and heart failure. Therefore, the objective of the trial is, to compare differences in oxygen uptake (peak VO2 \[l/min\]) and other physiological measures during similar cardiopulmonary exercise test protocols of eccentric- vs. concentric cycling in PH- patients and comparators with or without other cardiopulmonary diseases.
CONDITIONS
Official Title
Visa-versa! Breaking Instead of Pushing the Pedals-C
Who Can Participate
Eligibility Criteria
You may qualify if you...
- In a stable condition on the same disease specific medication >4 weeks.
- Signed informed consent.
- Patients with left-heart disease
You will not qualify if you...
- Severe daytime hypoxemia (pO2 �3E47.3 kPa or <55 mmHg).
- Other clinically significant concomitant disease states (e.g., renal, hepatic dysfunction).
- Inability to follow study procedures due to language, psychological, neurological, or orthopedic problems.
- Known pregnancy.
- Enrollment in another clinical trial with active treatment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Respiratory Clinic, University Hospital of Zurich
Zurich, Canton of Zurich, Switzerland, 8091
Actively Recruiting
Research Team
S
Silvia Ulrich, Prof. Dr.
CONTACT
J
Julian Müller, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here